FDA introduces orphan drug pilot scheme
carmendorin / iStockphoto.com
The Food and Drugs Administration (FDA) has cleared the backlog of orphan drug designation requests, one month early.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
FDA, Orphan Drug Act, Scott Gottlieb, Regulatory Affairs Professionals Society, Tufts Center for the Study of Drug Development,